News sentiment analysis powered by sentiment-insight.com
Shareholders Should Be Pleased With On Holding AG's (NYSE:ONON) Price
When close to half the companies in the Luxury industry in the United States have price-to-sales ratios (or "P/S") below 0.7x, you may consider On Holding AG (NYSE:ONON) as a stock to avoid entirely. On Holding certainly has been doing a good job lately as it's been growing revenue more than most other companies. The P/S is probably high because investors think this strong revenue performance will continue.
On Holding AG (NYSE:ONON) Q2 2023 Earnings Call Transcript On Holding AG (NYSE:ONON) Q2 2023 Earnings Call Transcript. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question-and-answer session. Thank you.
On Holding: Q2 Earnings Snapshot On Holding AG (ONON) on Tuesday reported second-quarter net income of $3.7 million. On a per-share basis, the Zurich-based company said it had profit of 1 cent. The results missed Wall Street expectations.
On Holding: Q1 Earnings Snapshot On Holding AG (ONON) on Tuesday reported first-quarter profit of $48 million. The Zurich-based company said it had profit of 15 cents per share. The running-shoe and apparel company posted revenue of $454.1 million.
On Holding: Q1 Earnings Snapshot On Holding AG (ONON) on Tuesday reported first-quarter profit of $48 million. The Zurich-based company said it had profit of 15 cents per share. The results topped Wall Street expectations.
On Holding: Q1 Earnings Snapshot On Holding AG (ONON) on Tuesday reported first-quarter profit of $48 million. The results topped Wall Street expectations. The running-shoe and apparel company posted revenue of $454.1 million.
Slowing Rates Of Return At On Holding (NYSE:ONON) Leave Little Room For Excitement On Holding (NYSE:ONON) has an ROCE of 7.5%. That's a low return, and it under-performs the Luxury industry average of 16%. There are better returns on capital out there than what we're seeing at On Holding. Over the past three years, On Holding has deployed 1,355% more capital into its operations.
Incyte Would Now Compete With Merck, Pfizer As Its Skin Cancer Treatment Scores FDA Accelerated Approval Shares of Swiss running-shoe company On Holding (NYSE: ONON) sprinted higher on Tuesday. AbbVie provided a regulatory update on its New Drug Application (NDA) for ABBV-951.
On Holding: Q4 Earnings Snapshot On Holding AG (ONON) on Tuesday reported a loss of $27.4 million in its fourth quarter. On a per-share basis, the Zurich-based company said it had a lost of 8 cents. The running-shoe and apparel company posted revenue of $380.9 million in the period.
On Holding: Q4 Earnings Snapshot On Holding AG (ONON) on Tuesday reported a loss of $27.4 million in its fourth quarter. On a per-share basis, the Zurich-based company said it had a lost of 8 cents. The running-shoe and apparel company posted revenue of $380.9 million in the period.
Sign Up
